Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Systematic and Evolutionary Microbiology
|
November 8, 2015
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens
Enrico Tortoli, Elvira Richter, Emanuele Borroni, et al.
International Journal of Systematic and Evolutionary Microbiology
|
October 1, 2015
Mycobacterium angelicum sp. nov., a non-chromogenic, slow-growing species isolated from fish and related to Mycobacterium szulgai
Fazel Pourahmad, Mateja Pate, Matjaž Ocepek, et al.
Mbio
|
October 23, 2014
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
Paolo Miotto, Andrea M Cabibbe, Silke Feuerriegel, et al.
Microbiology Spectrum
|
December 12, 2025
Clinical evaluation of a commercial culture-free targeted next-generation sequencing test for diagnosis of drug-resistant tuberculosis
Paolo Miotto, Rebecca E Colman, Andrea M Cabibbe, et al.
Archivos De Bronconeumologia
|
August 9, 2022
Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools
Laura Saderi, Mariangela Puci, Biagio Di Lorenzo, et al.
Scientific Reports
|
February 19, 2020
Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infections
Estefanía Abascal, Marta Herranz, Fermín Acosta, et al.
BMJ Open
|
November 28, 2024
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB
Kogieleum Naidoo, Anushka Naidoo, Alash'le G Abimiku, et al.
The Lancet. Infectious Diseases
|
March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
Álvaro H Borges, Marisa Russell, Dereck Tait, et al.
Nature Reviews. Microbiology
|
June 19, 2019
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
Conor J Meehan, Galo A Goig, Thomas A Kohl, et al.
The New England Journal of Medicine
|
October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
, Caroline Allix-Béguec, Irena Arandjelovic, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Systematic and Evolutionary Microbiology
|
November 8, 2015
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens
Enrico Tortoli, Elvira Richter, Emanuele Borroni, et al.
International Journal of Systematic and Evolutionary Microbiology
|
October 1, 2015
Mycobacterium angelicum sp. nov., a non-chromogenic, slow-growing species isolated from fish and related to Mycobacterium szulgai
Fazel Pourahmad, Mateja Pate, Matjaž Ocepek, et al.
Mbio
|
October 23, 2014
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study
Paolo Miotto, Andrea M Cabibbe, Silke Feuerriegel, et al.
Microbiology Spectrum
|
December 12, 2025
Clinical evaluation of a commercial culture-free targeted next-generation sequencing test for diagnosis of drug-resistant tuberculosis
Paolo Miotto, Rebecca E Colman, Andrea M Cabibbe, et al.
Archivos De Bronconeumologia
|
August 9, 2022
Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools
Laura Saderi, Mariangela Puci, Biagio Di Lorenzo, et al.
Scientific Reports
|
February 19, 2020
Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infections
Estefanía Abascal, Marta Herranz, Fermín Acosta, et al.
BMJ Open
|
November 28, 2024
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB
Kogieleum Naidoo, Anushka Naidoo, Alash'le G Abimiku, et al.
The Lancet. Infectious Diseases
|
March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
Álvaro H Borges, Marisa Russell, Dereck Tait, et al.
Nature Reviews. Microbiology
|
June 19, 2019
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
Conor J Meehan, Galo A Goig, Thomas A Kohl, et al.
The New England Journal of Medicine
|
October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
, Caroline Allix-Béguec, Irena Arandjelovic, et al.
Page
of 2